Trial Profile
Non-Phased Study of the Use of a Single Dose of Thymoglobulin for Immunosuppressive Induction in Renal Transplant Recipients as Compared to a Standard Four Dose Regimen.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 Oct 2009
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 27 Oct 2009 New trial record